In this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resorbable scaffold for the below-knee popliteal space.
Guest:
Dr. DeRubertis, is the Principal Investigator of the LIFE-BTK trial. He is the Chief of the Division of Vascular & Endovascular Surgery at New York-Presbyterian and Weill Cornell Medicine in New York City.
Audible Bleeding Team
Dr. Jamila Hedhliis a general surgery resident at the University of Illinois.
Anh Dang, (@QuynhAnh_Dang), is a fourth year medical student at the University of Pennsylvania.
Dr. Naveed A. Rahman, (@naveedrahmanmd), is a Vascular Surgery Fellow at the University of Maryland.
References:
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease (LIFE-BTK).
Advances in Endovascular Treatment of CLTI: Insights From the LIFE-BTK Trial.
The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
Follow us @audiblebleeding
Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.